Sarepta Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA. 

CEO
Douglas S. Ingram
CEODouglas S. Ingram
Employees
1,372
Employees1,372
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1980
Founded1980
Employees
1,372
Employees1,372

SRPT Key Statistics

Market cap
5.87B
Market cap5.87B
Price-Earnings ratio
26.41
Price-Earnings ratio26.41
Dividend yield
Dividend yield
Average volume
2.07M
Average volume2.07M
High today
$61.92
High today$61.92
Low today
$59.96
Low today$59.96
Open price
$61.68
Open price$61.68
Volume
1.31M
Volume1.31M
52 Week high
$173.25
52 Week high$173.25
52 Week low
$48.01
52 Week low$48.01

SRPT News

Benzinga 4d
Netflix To Rally More Than 55%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please...

Netflix To Rally More Than 55%? Here Are 10 Top Analyst Forecasts For Monday
Simply Wall St 6d
Sarepta Therapeutics, Inc. Not Doing Enough For Some Investors As Its Shares Slump 27%

To the annoyance of some shareholders, Sarepta Therapeutics, Inc. ( ) shares are down a considerable 27% in the last month, which continues a horrid run for the...

Sarepta Therapeutics, Inc. Not Doing Enough For Some Investors As Its Shares Slump 27%

Analyst ratings

84%

of 25 ratings
Buy
84%
Hold
16%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.